Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 13/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | IDO1 | P14902 | 2/20 | 0.31 |
| ▸ | LTA4H | P09960 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.30 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL473606 | 0.86 | CHRNB2 (0.34) | CA1CA2CA9CYP3A4CHRNB2 | |
| SCHEMBL11965976 | 0.78 | ESR2 (0.33) | CYP3A4CHRNB2CHRNA4 | |
| SCHEMBL14289128 | 0.78 | ALDH1A1 (0.44) | CYP3A4LTA4H | |
| SCHEMBL194685 | 0.74 | LMNA (0.42) | APPCA1CA2CA9CYP3A4 | |
| SCHEMBL14605389 | 0.74 | IDO1 (0.33) | IDO1CHRNB2CHRNA4 | |
| SCHEMBL17186614 | 0.74 | NPC1 (0.32) | CHRNB2CHRNA4 | |
| SCHEMBL274124 | 0.74 | CA1 (0.58) | CA1CA2CA9CYP3A4LTA4H | |
| SCHEMBL194091 | 0.74 | ACHE (0.48) | CA1CA2CA9CYP3A4 | |
| SCHEMBL2161453 | 0.74 | CA1 (0.43) | APPCA1CA2CA9CYP3A4 | |
| SCHEMBL126186 | 0.74 | ALDH1A1 (0.58) | CYP3A4CHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022173756-A1 | ANTIBACTERIAL COMPOUNDS | FORGE THERAPEUTICS, INC. (US) | 2022-08-18 | — | — | WO | disclosed |
| EP-1394153-B1 | THIOL COMPOUND DERIVATIVES, HARDENING COMPOSITIONS CONTAINING THESE DERIVATIVES AND MOLDED ARTICLES THEREOF | UNIMATEC CO LTD (JP) | 2010-12-29 | — | — | EP | disclosed |
| US-7812157-B2 | Thiol compound derivative, curable composition containing the derivative, and molded product thereof | UNIMATEC CO., LTD. (JP) | 2010-10-12 | — | — | US | disclosed |
| US-20080227977-A1 | Thiol compound derivative, curable composition containing the derivative, and molded product thereof | UNIMATEC CO., LTD. | 2008-09-18 | — | — | US | disclosed |
| US-7384995-B2 | Thiol compound derivative, curable composition containing the derivative, and molded product thereof | UNIMATEC CO., LTD. (JP) | 2008-06-10 | — | — | US | disclosed |
| US-20070155868-A1 | Thiol compound derivative, curable composition containing the derivative, and molded product thereof | UNIMATEC CO., LTD. | 2007-07-05 | — | — | US | disclosed |
| US-7199169-B2 | Thiol compound derivative, hardening compositions containing these derivatives and molded articles thereof | UNIMATEC CO., LTD. (JP) | 2007-04-03 | — | — | US | disclosed |
| US-20040162368-A1 | Thiol compound derivative, hardening compositions containing these derivatives and molded articles thereof | UNIMATEC CO., LTD. (JP) | 2004-08-19 | — | — | US | disclosed |
| EP-1394153-A1 | THIOL COMPOUND DERIVATIVES, HARDENING COMPOSITIONS CONTAINING THESE DERIVATIVES AND MOLDED ARTICLES THEREOF | Unimatec Co., Ltd. (JP) | 2004-03-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080227977-A1 | Thiol compound derivative, curable composition containing the derivative, and molded product thereof | TST, CTH, NACA | APP 3221/4885CA1 1279/4885CA2 3511/4885 |
| US-20040162368-A1 | Thiol compound derivative, hardening compositions containing these derivatives and molded articles thereof | TST, NACA, CTH | APP 3254/4885CA1 2153/4885CA2 3843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.